Medtronic reported second-quarter profit and revenue above Wall Street estimates on Tuesday, driven by strong demand for its ...

MDT posts Q2 earnings and revenue beat, powered by strong Cardiovascular growth and a raised 2026 outlook that lifts its ...

"In sum, although the court previously rejected (and thus did not consider) the application of a but-for causation standard, ...

Medtronic beat second-quarter estimates and raised annual sales growth forecast on Tuesday, driven by strong demand for heart ...

Medtronic posted a slate of strong quarterly financial results this morning, with its cardiovascular device portfolio pushing ...

Medtronic’s quarterly report was the first in nine months in which it did not announce major shakeups. The company said in ...

Medtronic (MDT) stock rises as the company beats forecasts with its Q2 financials thanks to cardiovascular unit and raises ...

Looking ahead to next year, we continue to expect high single-digit EPS growth in fiscal year 2027 driven by accelerating ...

Analysts expect the Galway, Ireland-based company to report quarterly earnings of $1.31 per share, up from $1.26 per share in ...

Medtronic fiscal year 2026 revenue gains include a 6.6% increase to $9 billion and raised full-year growth guidance to 5.5%.

I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.

The medical-device maker said Tuesday it now expects organic revenue to grow about 5.5% from its last fiscal year, compared with a prior outlook of up 5%. The company also raised the low end of its ...